SOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing […]
**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United […]